Literature DB >> 33139493

Elevated MicroRNA 183 Impairs Trophoblast Migration and Invasiveness by Downregulating FOXP1 Expression and Elevating GNG7 Expression during Preeclampsia.

Weisi Lai1, Ling Yu2.   

Abstract

Preeclampsia (PE) is a hypertensive disorder of uncertain etiology that is the leading cause of maternal and fetal morbidity or mortality. The dysregulation of microRNAs (miRNAs) has been highlighted as a potential factor involved in the development of PE. Therefore, our study investigated a novel miRNA, miRNA 183 (miR-183), and its underlying association with PE. Expression of miR-183, forkhead box P1 (FOXP1), and G protein subunit gamma 7 (GNG7) in placental tissues of patients with PE was determined. Gain- and loss-of-function experiments were conducted to explore modulatory effects of miR-183, FOXP1, and GNG7 on the viability, invasion, and angiogenesis of trophoblast cells in PE. Finally, we undertook in vivo studies to explore effects of FOXP1 in the PE model. The results revealed suppressed expression of FOXP1 and significant elevations in miR-183 and GNG7 expression in placental tissues of PE patients. FOXP1 was observed to promote proliferation, invasion, and angiogenesis in human chorionic trophoblastic cells. miR-183 resulted in depletion of FOXP1 expression, while FOXP1 was capable of restraining GNG7 expression and promoting the mTOR pathway. The findings confirmed the effects of FOXP1 on PE. In conclusion, miR-183 exhibits an inhibitory role in PE through suppression of FOXP1 and upregulation of GNG7.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  G protein subunit gamma 7; Preeclampsia; forkhead box P1; mechanistic target of rapamycin kinase; microRNA-183

Mesh:

Substances:

Year:  2020        PMID: 33139493      PMCID: PMC7849397          DOI: 10.1128/MCB.00236-20

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

Review 1.  Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.

Authors:  Peter Kaufmann; Simon Black; Berthold Huppertz
Journal:  Biol Reprod       Date:  2003-03-05       Impact factor: 4.285

2.  Foxp1 is an essential transcriptional regulator of B cell development.

Authors:  Hui Hu; Bin Wang; Madhuri Borde; Julie Nardone; Shan Maika; Laura Allred; Philip W Tucker; Anjana Rao
Journal:  Nat Immunol       Date:  2006-07-02       Impact factor: 25.606

3.  Sexual Dimorphisms of Preeclampsia-Dysregulated Transcriptomic Profiles and Cell Function in Fetal Endothelial Cells.

Authors:  Chi Zhou; Qin Yan; Qing-Yun Zou; Xin-Qi Zhong; Chanel T Tyler; Ronald R Magness; Ian M Bird; Jing Zheng
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

4.  TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia.

Authors:  Biwei He; Xingyu Yang; Yamei Li; Ding Huang; Xin Xu; Wenjun Yang; Yan Dai; Huijuan Zhang; Zhengjun Chen; Weiwei Cheng
Journal:  Hypertension       Date:  2018-02-05       Impact factor: 10.190

5.  FOXP1 inhibits high glucose-induced ECM accumulation and oxidative stress in mesangial cells.

Authors:  Heli Xiang; Wujun Xue; Xiaoyan Wu; Jin Zheng; Chenguang Ding; Yang Li; Meng Dou
Journal:  Chem Biol Interact       Date:  2019-09-05       Impact factor: 5.192

6.  G Protein α Subunit 14 Mediates Fibroblast Growth Factor 2-Induced Cellular Responses in Human Endothelial Cells.

Authors:  Qing-Yun Zou; Ying-Jie Zhao; Chi Zhou; Ai-Xia Liu; Xin-Qi Zhong; Qin Yan; Yan Li; Fu-Xian Yi; Ian M Bird; Jing Zheng
Journal:  J Cell Physiol       Date:  2018-11-01       Impact factor: 6.384

7.  Preeclampsia Is Associated With Increased Preclinical Carotid Atherosclerosis in Women With Type 1 Diabetes.

Authors:  Antonio J Amor; Irene Vinagre; Maite Valverde; Adriana Pané; Xavier Urquizu; Eva Meler; Eva López; Carmen Quirós; Marga Giménez; Laura Codina; Ignacio Conget; Maria J Barahona; Verónica Perea
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

8.  Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women: A Systematic Review and Meta-Analysis.

Authors:  Swati Agrawal; Shiri Shinar; Ana Sofia Cerdeira; Christopher Redman; Manu Vatish
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

9.  Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs.

Authors:  A B Niculescu; H Le-Niculescu; D F Levey; K Roseberry; K C Soe; J Rogers; F Khan; T Jones; S Judd; M A McCormick; A R Wessel; A Williams; S M Kurian; F A White
Journal:  Mol Psychiatry       Date:  2019-02-12       Impact factor: 15.992

Review 10.  From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.

Authors:  Sonya Frazier; Martin W McBride; Helen Mulvana; Delyth Graham
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

View more
  3 in total

Review 1.  Non-Coding RNAs Regulate Placental Trophoblast Function and Participate in Recurrent Abortion.

Authors:  Xin Chen; Duan-Ying Guo; Tai-Lang Yin; Jing Yang
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 2.  Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia.

Authors:  Heyam Hayder; Yanan Shan; Yan Chen; Jacob Anderson O'Brien; Chun Peng
Journal:  Front Cell Dev Biol       Date:  2022-10-03

3.  Overexpression of microRNA-100-5p attenuates the endothelial cell dysfunction by targeting HIPK2 under hypoxia and reoxygenation treatment.

Authors:  Haoyu Zheng; Yanlan Sun; Xiaoming Shu; Qiong Gao; Xiaoqin Chen
Journal:  J Mol Histol       Date:  2021-07-02       Impact factor: 2.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.